In long-term follow-up, Diabetes Prevention Program participants randomized to metformin during the trial continue to have lower rates of developing type 2 diabetes.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
